What is ELAB stock price today?

ELAB (Pmgc Holdings Inc) stock is trading at $1.78 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ELAB stock going up or down today?

ELAB stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ELAB stock now?

The decision to buy ELAB depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ELAB a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ELAB based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ELAB stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ELAB is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ELAB's P/E ratio?

P/E ratio data for ELAB will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ELAB's market cap?

ELAB (Pmgc Holdings Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is ELAB's price to book ratio?

ELAB trades at a price-to-book (P/B) ratio of 0.64, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ELAB pay dividends?

ELAB does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ELAB's dividend yield?

ELAB does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ELAB stock a good long-term investment?

ELAB's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ELAB's revenue growth rate?

ELAB has shown revenue growth of -0.5% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for ELAB are available on our dashboard with complete income statement analysis.

What are the risks of investing in ELAB?

Key risks for ELAB include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ELAB compare to its competitors?

Compare ELAB to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ELAB's performance and positioning.

What is ELAB's stock price target for 2026?

Our AI model provides price targets for ELAB based on fundamental analysis: Bull case $2.31 (+30%), Base case $2.05 (+15%), Bear case $1.60 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ELAB?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ELAB. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ELAB's next earnings report?

ELAB reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ELAB - Pmgc Holdings Inc

NYSE * Health Care * Biotechnology

$1.78

+$0.12 (+7.23%)

About Pmgc Holdings Inc

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

ELAB Key Statistics

Market Cap

$8.09M

P/B Ratio

0.64

EPS

$-150.06

Revenue Growth

-0.5%

Employees

How ELAB Compares to Peers

ELAB is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ELAB(This stock)	$8.09M	N/A	-0%	0.0%	-
AMGNAmgen Inc	$183.12B	23.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$166.82B	18.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$110.28B	25.8	0%	0.4%	vs VRTX
REGNRegeneron Pharmaceuticals	$66.98B	15.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$28.61B	20.8	0%	0.1%	vs BIIB

Pmgc Holdings Inc Company Information

Headquarters: California; U.S.A
Website: pmgcholdings.com
Sector: Health Care
Industry: Biotechnology

ELAB - Pmgc Holdings Inc

About Pmgc Holdings Inc

ELAB Key Statistics

How ELAB Compares to Peers

Pmgc Holdings Inc Company Information

ELAB Lician Score

ELAB Financial Snowflake

Upcoming Events for ELAB